Adjuvants and delivery technologies.
Killeen
Kevin P
KP
Matrivax Research & Development Corp, Boston, MA, USA. kpkilleen@matrivax.com
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D051193:Toll-Like Receptors / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D051193:Toll-Like Receptors; D014612:Vaccines